GW 780604,
GW 786034B,
GW-780604,
GW-786034B,
GW780604,
GW786034B,
pazopanib,
Votrient,
Pazopanib,
444731-52-6,
GW786034,
UNII-7RN5DR86CK,
Pazopanib (GW-786034),
7RN5DR86CK,
GW 78603,
790713-33-6,
CHEBI:71219,
MFCD11616589,
GW 786034,
NCGC00188865-01,
GW-786034,
DSSTox_CID_28659,
DSSTox_RID_82929,
DSSTox_GSID_48733,
5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide,
5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide,
5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide,
5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide,
Q-101400,
C21H23N7O2S,
5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide,
5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide,
5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide,
CAS-444731-52-6,
Pazopanib [INN:BAN],
pazopanibum,
HSDB 8210,
Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-,
Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-,
indazolylpyrimidine 13,
Pazopanib (free base),
Kinome_3790,
PubChem22448,
GW7 86034,
Pazopanib/GW-786034,
SCHEMBL588608,
CHEMBL477772,
GTPL5698,
JMC514632 Compound 13,
DTXSID8048733,
BDBM26474,
QCR-110,
SYN1058,
cid_10113978,
CUIHSIWYWATEQL-UHFFFAOYSA-N,
BCPP000129,
HMS3244C21,
HMS3244C22,
HMS3244D21,
HMS3656L14,
AOB87179,
BCP01839,
EX-A1241,
Tox21_113174,
ABP000868,
ABP000882,
AN-050,
NSC752782,
RS0094,
s3012,
ZINC11617039,
AKOS005145819,
Tox21_113174_1,
AC-8522,
API0024403,
BCP9001053,
CS-0269,
DB06589,
MCULE-2193898201,
NSC-752782,
SB17290,
NCGC00188865-02,
NCGC00188865-03,
NCGC00188865-10,
AS-11066,
BC280878,
HY-10208,
SC-23290,
AB0008634,
AB1008452,
AX8161907,
AM20090659,
FT-0659928,
FT-0684794,
ST24031511,
SW218082-3,
Pazopanib Hydrochloride /GW786034,VOTRIENT,
A11518,
A19406,
P-6706,
Q-1426,
S-7750,
AB01273967-01,
AB01273967-02,
AB01273967_05,
AB01273967_06,
A839572,
I09-0358,
BRD-K74514084-003-02-7,
Z1541638525,
5-(3-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)phenylamino)-2-methylbenzenesulfonamide,
5-({4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide,
5-({4-[(2,3-dimethylindazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide,
5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide,
5-[[4-[(2,3-dimethyl-6-indazolyl)-methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide,
5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide,
Votrient,
pazopanib HCl,
Pazopanib hydrochloride,
Pazopanib [INN],
GW786034B,
ACN-034472,
CS-O-02101,
CID10113978,
A3022,
635702-64-6,
5-(4-(N-(2,3-diMethyl-2H-indazole-6-yl)- N-MethylaMino)pyriMidine-2-ylaMino)-2-MethylbenzenesulfonaMide,
5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide,
N4(2,3-dimethyl-2H-indazol-6-yl)-N4-methyl-N2-(4-methyl-3-sulfonamidophenyl)-2,4-pyrimidinediamine,